中国“蔡司”耐德佳完成C3轮融资，石景山区产业基金投资

Group 1: Company Overview - Beijing Naidejia Display Technology Co., Ltd. (Naidejia) has completed its C3 round of financing, with the investment coming from the Shijingshan District Modern Innovation Industry Development Fund in Beijing [2] - Naidejia has successfully completed three rounds of financing within a year, having previously secured investments from Hefei Construction Investment, Baohe Innovation Investment, and Beijing New Materials Fund [2][3] - The company has established deep cooperative relationships with top global companies and leading hospitals in the ophthalmology field, including Lenovo, Xiaomi, and Aier Eye Hospital [2] Group 2: Technological Advancements - Naidejia has achieved significant breakthroughs in optical technology, including mass production of freeform surface products and advancements in waveguide technology [4] - The company has innovated processes such as molecular bonding and high-precision glass polishing, leading to the development of a full-color, high-transmittance two-dimensional array waveguide product matrix [4] - Naidejia has pioneered the development of distant imaging technology in the health display optical field, creating new product categories such as distant imaging screens and folding reading tables, with over 200 patents filed [4] Group 3: Market Position and Impact - The reading tables developed and manufactured by Naidejia have captured 80% of the market share in this category, providing new solutions for eye health management in near-vision scenarios [5] - The number of myopic patients under 20 in China is projected to reach 187 million by 2025, with a current myopia rate of 51.9% among children and adolescents, highlighting a significant public health issue [5] - The company expresses a strong commitment to addressing the growing demand for vision improvement solutions in light of the alarming statistics regarding myopia among youth [5]